...
【24h】

The role of HPaA protein as candidate vaccine against Helicobacter pylori

机译:HPaA蛋白作为抗幽门螺杆菌候选疫苗的作用

获取原文
           

摘要

Scientists affirmed Helicobacter pylori as strict cause of cancer in humans and type I carcinogen. According to the reports, H. pylori infection occurs in more than half of the world population. Generally H.pylori is accountable for nearby 75% of the entire gastric cancers and 63.4% of the entire stomach cancers over the world. Given the importance of this bacterium and emergence of drug resistant strains need to appropriate vaccine forer abdication of pathogenic strains is felt. The role of UreB, HspA, FlaA, FlaB, CagA, VacA, HpaA as candidate vaccine has been established. For bacterial proteins act as a candidate vaccine antigen, it should preferably be conserved, immunogenic, secreted or surface localized. HpaA protein has all these criteria. According to the conducted studies HpaA protein is a good candidate in the development of vaccines against H. pylori infection, but this factor for inducing appropriate immune responses should be used in combination with the other factors that participating in pathogenesis of infection.
机译:科学家确认幽门螺杆菌是人类和I型致癌物致癌的严格原因。据报道,幽门螺杆菌感染发生在世界一半以上的人口中。通常,幽门螺杆菌占全世界全部胃癌的近75%和全部胃癌的63.4%。考虑到该细菌的重要性和耐药菌株的出现,需要对致病菌株进行适当的疫苗前消退。已经确定了UreB,HspA,FlaA,FlaB,CagA,VacA,HpaA作为候选疫苗的作用。由于细菌蛋白可作为候选疫苗抗原,因此最好将其保守,免疫原性,分泌或表面定位。 HpaA蛋白具有所有这些标准。根据进行的研究,HpaA蛋白是开发抗幽门螺杆菌感染疫苗的良好候选者,但是该诱导适当免疫反应的因子应与参与感染发病机制的其他因子结合使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号